Associate Professor
Centre for Interdisciplinary Sciences, JISIASR (Year of joining 2022)
Post-Doc (2010): Centre for Immunology and Infection, The Hull York Medical School, University of York, U.K.
Post-Doc (2002-03): NIAID, National Institutes of Health, Bethesda, MD, USA
Ph.D. (1994-1999): Jadavpur University, Kolkata, West Bengal
M.Sc. (1991-1993): Biotechnology, Aligarh Muslim University, U.P.
Email: afrin@jisiasr.org
Researcher ID (Web of Science): F-2346-2018
Author ID (Scopus): 6602621730
ORCID ID: 0000-0003-4443-4284
Loop profile: 119563
URLs:https://vidwan.inflibnet.ac.in/profile/278778
https://jisiasr.org/dr-farhat-afrin/
https://orcid.org/0000-0003-4443-4284
https://www.scopus.com/authid/detail.uri?authorId=6602621730
https://scholar.google.com/citations?user=SwSWeiYAAAAJ&hl=en&oi=ao
https://www.linkedin.com/in/farhat-afrin-2b345870/
https://www.researchgate.net/profile/Farhat-Afrin
Professional Engagements:
2022- Till Date: Associate Professor, Centre for Interdisciplinary Sciences,
JISIASR, Kolkata, JIS University, West Bengal
2014-2019: Assistant Professor, Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, Taibah University, Madina, Saudi Arabia
2006-2014: Assistant Professor, Department of Biotechnology, Jamia Hamdard (Hamdard University), New Delhi, India
2003-2005: Lecturer (Sr. scale), Department of Biotechnology, Hamdard University, New Delhi, India
1999-2003: Lecturer, Department of Biotechnology, Hamdard University, New Delhi, India
1998-1999: Lecturer (Adhoc), Department of Biotechnology, Hamdard University, New Delhi, India
Research Areas of Specialization:
Main Area: Biotechnology/ Molecular Medicine; Sub-area: Immunology/ Nanomedicine/Herbal Medicine/ Epigenetics
Area (Specialization):Our research encompasses vaccinology, immune-therapeutics, herbal- and nanomedicine and epigenetic changes in infectious diseases. We are currently investigating therapeutic interventions of infectious diseases, leishmaniasis and cancer using herbal medicines and nanoparticles alone or as drug carriers.Prophylactic and therapeutic nano-vaccines against leishmaniasis and other infectious diseasesis also being explored.Epigenetic modifications during disease pathogenesis and treatment are also being studied.
Academic Expertise
Teaching Experience (post-Ph.D.) :24 years (1999 – Till Date)
Research Experience :29 years (1994 – Till Date);
post-Ph.D. – 24 years (1999 – Till Date)
Publications
Book Chapters published and role : 3 (As Corresponding author)
Books published and role : 2 (As Editor); 1 (As Co-Editor)
Research papers published and role : 64 (Web of Science), 61 (Scopus)
Total citations : 2188 (Web of Science), 2502 (Scopus)
h-index : 29 (Web of Science), 33 (Scopus)
Cumulative impact factor : 229
Research Guidance
Number of Ph.D. students supervised and role: 4 (As Supervisor); 11 (As Co-Supervisor)
Number of Masters (Biotechnology) students supervised and role: 61 (As Supervisor)
Number of Bachelors (Medical Laboratory Technology) students supervised and role: 9 (As Supervisor)
Research Grants /Projects Awarded/Completed (with role and budget amount): Four as Principal Investigator (Rs. 146.628 Lakhs); One as Co-Investigator (Rs. 37.98696 Lakhs)
Editorial Board Member of Peer Reviewed International Journals/ Books: 23
Reviewer of International Journals: 62
Research Paper Presentations/ Chairing Session in Conference/Keynote Speaker: 39
Abstracts from Proceedings of Seminars/Symposia/Workshops: 98
Collaborations with Research Institutes/ Universities:11
Life Membership in Professional Societies: 3
